Janus Henderson Group PLC Eliem Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,184,200 shares of ELYM stock, worth $13.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,184,200
Previous 3,606,495
11.71%
Holding current value
$13.1 Million
Previous $18.4 Million
28.71%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ELYM
# of Institutions
76Shares Held
51MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.09% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA2.61MShares$10.7 Million3.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$6.19 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.04MShares$4.27 Million0.19% of portfolio
-
Bank Of America Corp Charlotte, NC1.03MShares$4.25 Million0.0% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...